期刊
LANCET
卷 396, 期 10250, 页码 565-582出版社
ELSEVIER SCIENCE INC
关键词
-
资金
- US National Institutes of Health [DK074970, DK107444, AG026572, AG057931, AG059093, AG053589, HL105339, HL114501, HL132825, AG062333, NS08779, NS096493, HD057022, HL119380, AG060730, CA174737]
- US Department of Veterans Affairs Merit Review Awards [BX003725, CX001532]
- Swedish Research Council [2019-01059]
- Anna Fischer Dueckelman guest professorship at the University of Zurich
Clinicians can encounter sex and gender disparities in diagnostic and therapeutic responses. These disparities are noted in epidemiology, pathophysiology, clinical manifestations, disease progression, and response to treatment. This Review discusses the fundamental influences of sex and gender as modifiers of the major causes of death and morbidity. We articulate how the genetic, epigenetic, and hormonal influences of biological sex influence physiology and disease, and how the social constructs of gender affect the behaviour of the community, clinicians, and patients in the health-care system and interact with pathobiology. We aim to guide clinicians and researchers to consider sex and gender in their approach to diagnosis, prevention, and treatment of diseases as a necessary and fundamental step towards precision medicine, which will benefit men's and women's health.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据